Published in N Engl J Med on June 12, 1975
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest (1977) 5.09
Interstitial mononuclear cell populations in renal graft rejection. Identification by monoclonal antibodies in tissue sections. J Exp Med (1982) 1.59
Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A (1997) 1.48
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology (2010) 1.39
Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant (2008) 1.15
Emergence of insulin receptors upon alloimmune T cells in the rat. J Clin Invest (1977) 1.09
Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo. J Exp Med (1984) 1.07
Mechanisms of corticosteroid action on lymphocyte subpopulations. III. Differential effects of dexamethasone administration on subpopulations of effector cells mediating cellular cytotoxicity in man. Clin Exp Immunol (1978) 1.03
T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest (1986) 0.98
Identification of cells expressing T and p28,33 (Ia-like) antigens in sections of human lymphoid tissue. Clin Exp Immunol (1980) 0.97
Ultrastructure of cells infiltrating human kidney allografts. Clin Exp Immunol (1976) 0.96
Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection. Am J Pathol (2011) 0.86
The divergent roles of macrophages in solid organ transplantation. Curr Opin Organ Transplant (2015) 0.81
Factors affecting the autologous mixed lymphocyte reaction in kidney transplantation. J Clin Invest (1983) 0.80
The migrant cells in allotransplants of heart, kidney and skin. 1. A comparative electron microscopic analysis of the migrant cells. Br J Exp Pathol (1977) 0.80
Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling. Transplant Rev (Orlando) (2014) 0.79
Expansion and somatic hypermutation of B-cell clones in rejected human kidney grafts. Transplantation (2014) 0.77
Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies. Front Immunol (2016) 0.77
2006 Homer W. Smith Lecture: taming T cells. J Am Soc Nephrol (2007) 0.77
Retrospective screening for lymphocyte-dependent antibody in recipients of renal transplants. Clin Exp Immunol (1977) 0.75
Transplantation: a new molecular approach to the diagnosis of acute rejection. Nat Rev Nephrol (2013) 0.75
Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic Mice. Stem Cell Reports (2015) 0.75
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med (2000) 11.90
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science (2000) 9.92
Patterns of lymphatic drainage in the adult laboratory rat. J Anat (1971) 4.15
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity (1997) 4.05
Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med (1998) 3.54
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34
Renal transplantation. N Engl J Med (1994) 3.33
B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity (1997) 3.22
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med (1999) 3.17
Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. J Exp Med (1983) 2.94
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74
Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol (1986) 2.68
Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant (2007) 2.61
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci (1992) 2.47
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med (2001) 2.29
The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest (1997) 2.28
Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines. J Immunol (1984) 2.26
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med (1987) 2.16
The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1. J Immunol (1985) 2.14
Cytomegalovirus infection after renal allotransplantation. JAMA (1967) 2.08
Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med (1984) 2.03
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01
The high cost of low-frequency events: the anatomy and economics of surgical mishaps. N Engl J Med (1981) 1.94
The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med (1973) 1.92
Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Natl Acad Sci U S A (1972) 1.85
Immunohistochemistry of glomerulonephritis using horseradish peroxidase and fluorescein-labeled antibody: a comparison of two technics. Am J Clin Pathol (1970) 1.79
Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest (1997) 1.77
Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol (1987) 1.73
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62
A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice. J Immunol (1985) 1.58
CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int (1997) 1.57
Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57
Rapamycin induces transforming growth factor-beta production by lymphocytes. Transplantation (2000) 1.56
Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant (2010) 1.55
Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation (1995) 1.53
The systemic distribution of soluble antigen injected into the footpad of the laboratory rat. Immunology (1970) 1.51
T cell death and transplantation tolerance. Immunity (2001) 1.51
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc Natl Acad Sci U S A (2000) 1.50
Human renal allografts. The role of vascular injury in early graft failure. Medicine (Baltimore) (1971) 1.49
The role of antibodies in the rejection and enhancement of organ allografts.?7318. Adv Immunol (1976) 1.48
Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A (1997) 1.48
CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J Immunol (1997) 1.47
Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol (2000) 1.45
Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest (1978) 1.44
Chronic thoracic duct fistula: operative technic and physiologic effects in man. Ann Surg (1968) 1.42
The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest (1997) 1.42
Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation. Am J Med (1967) 1.42
Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg (1985) 1.40
Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc (1969) 1.39
A broadening of vision: observation on the practice of surgery in a university hospital in Great Britain. Surgery (1974) 1.39
Non-heartbeating kidney donors. Clin Transplant (1999) 1.37
Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma. J Clin Invest (1984) 1.36
Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest (1970) 1.35
Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci U S A (1995) 1.34
Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J Exp Med (1985) 1.34
The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement. J Exp Med (1976) 1.33
Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J Immunol (1998) 1.32
Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol (1998) 1.32
Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J Immunol (1995) 1.29
Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparations. Tissue Antigens (1979) 1.29
Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest (1980) 1.29
Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med (1984) 1.28
Synthetic polypeptide metabolism. 3. Degradation and organ localization of isomeric synthetic polypeptide antigens. J Immunol (1967) 1.28
Hereditary C2 deficiency: diagnosis and HLA gene complex associations. J Immunol (1976) 1.28
Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics. Transplantation (1981) 1.28
Sequential system failure after rupture of abdominal aortic aneurysms: an unsolved problem in postoperative care. Ann Surg (1973) 1.28
Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations. Am J Transplant (2009) 1.27
The sensitization of rats by allografts transplanted to alymphatic pedicles of skin. J Exp Med (1971) 1.27
Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Protein Eng (1987) 1.27
Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model. Transplantation (1992) 1.26
Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells. J Biol Chem (1990) 1.26
Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. J Biol Chem (1991) 1.26
Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J Immunol (1996) 1.24
Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol (1999) 1.24
Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation (1993) 1.24
Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein. J Exp Med (1988) 1.23
Heparin and aspirin in the treatment of hyperacute rejection of renal allografts in presensitized dogs. Transplantation (1970) 1.23
Small intestine transplantation in the rat--immunology and function. Surgery (1984) 1.23
Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation (1967) 1.22
Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation (1998) 1.22